103 related articles for article (PubMed ID: 1583084)
21. Biophotometric comparison of cephalexin and cephradine against gram-positive bacteria.
Brumfitt W; Hamilton-Miller JM
Chemotherapy; 1982; 28(1):40-5. PubMed ID: 7035090
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetic comparison of cefroxadin (CGP 9000) and cephalexin by simultaneous administration to humans.
Lecaillon JB; Hirtz JL; Schoeller JP; Humbert G; Vischer W
Antimicrob Agents Chemother; 1980 Nov; 18(5):656-60. PubMed ID: 7447423
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of cephradine administered intravenously and orally to young and elderly subjects.
Schwinghammer TL; Norden CW; Gill E
J Clin Pharmacol; 1990 Oct; 30(10):893-9. PubMed ID: 2229449
[TBL] [Abstract][Full Text] [Related]
24. Clinical pharmacokinetics of five oral cephalosporins in calves.
Soback S; Ziv G; Kurtz B; Paz R
Res Vet Sci; 1987 Sep; 43(2):166-72. PubMed ID: 3317582
[TBL] [Abstract][Full Text] [Related]
25. Iodmetric and spectrophotometric assays for cephradine after its hydrolysis with a beta-lactamase.
Frantz BM
J Pharm Sci; 1976 Jun; 65(6):887-91. PubMed ID: 819645
[TBL] [Abstract][Full Text] [Related]
26. Biophotometric investigations on the influence of cephradine and related cephalosporins on the growth of beta-lactamase-producing staphylococi.
Breuer A; Starke B
Arzneimittelforschung; 1978; 28(8):1327-30. PubMed ID: 313798
[TBL] [Abstract][Full Text] [Related]
27. Effects of test conditions on the susceptibility of staphylococci in vitro to cephradine, cephaloridine, cephalexin, and cefuroxime.
Bayston R; Swinden J
J Clin Pathol; 1981 Feb; 34(2):203-7. PubMed ID: 7229101
[TBL] [Abstract][Full Text] [Related]
28. Determination of cefaclor and cephradine in serum by ion-pair reversed-phase chromatography.
Lindgren K
J Chromatogr; 1987 Jan; 413():351-4. PubMed ID: 3558691
[No Abstract] [Full Text] [Related]
29. Pharmacokinetics of oral cephradine in continuous ambulatory peritoneal dialysis patients.
Johnson CA; Welling PG; Zimmerman SW
Nephron; 1984; 38(1):57-61. PubMed ID: 6472532
[TBL] [Abstract][Full Text] [Related]
30. [Bioavailability of new galenic preparations of cephalexin (author's transl)].
Guggenbichler JP; Kienel G
Padiatr Padol; 1978; 13(3):315-20. PubMed ID: 673437
[TBL] [Abstract][Full Text] [Related]
31. A randomized double-blind investigation of cefroxadine (CGP 9000) versus cephalexin in urinary tract infection.
Hess J; Gammelgaard P; Holst B; Rasmussen F; Thomsen VF
Infection; 1984; 12(4):270-3. PubMed ID: 6436182
[TBL] [Abstract][Full Text] [Related]
32. [Cefroxadine and cephalexin in urinary tract infections. Kinetics of germ elimination].
Naber KG; Ahrens T
Fortschr Med; 1982 Oct; 100(39):1827-31. PubMed ID: 6759334
[TBL] [Abstract][Full Text] [Related]
33. Antimicrobial agents in rats. II. Serum levels of oral cephalosporins.
Marre R; Freiesleben H; Beck H; Sack K
Arzneimittelforschung; 1979; 29(7):990-2. PubMed ID: 115480
[TBL] [Abstract][Full Text] [Related]
34. The role of cefadroxil in the therapy of urinary tract infections.
Wilber RB; DeRegis RG; Fox EJ
J Antimicrob Chemother; 1982 Sep; 10 Suppl B():77-84. PubMed ID: 7142098
[No Abstract] [Full Text] [Related]
35. Transepithelial transport of oral cephalosporins by monolayers of intestinal epithelial cell line Caco-2: specific transport systems in apical and basolateral membranes.
Inui K; Yamamoto M; Saito H
J Pharmacol Exp Ther; 1992 Apr; 261(1):195-201. PubMed ID: 1560365
[TBL] [Abstract][Full Text] [Related]
36. Double-blind comparison of cephradine and cephalexin in the treatment of skin and soft-tissue infections due to Staphylococcus aureus.
Hubsher JA; Gadebusch HH; Itkin AG
Curr Ther Res Clin Exp; 1976 Jun; 19(6):579-88. PubMed ID: 819217
[No Abstract] [Full Text] [Related]
37. Cephradine and cephalexin in the treatment of children with bacterial pneumonia.
Alban J; Caloza DL
Curr Ther Res Clin Exp; 1975 Oct; 18(4):539-45. PubMed ID: 241608
[No Abstract] [Full Text] [Related]
38. Effect of ionization on absorption of cephalosporins.
DeYoung JL; Tan HG; Huber HE; Zoglio MA
J Pharm Sci; 1978 Mar; 67(3):320-3. PubMed ID: 25323
[TBL] [Abstract][Full Text] [Related]
39. Activity of cefroxadine and cephalexin in urinary tract infections: a double-blind comparative study.
Ahrens T; Naber KG
Infection; 1983; 11(1):25-30. PubMed ID: 6341252
[TBL] [Abstract][Full Text] [Related]
40. High-performance liquid chromatographic determination of loracarbef, a potential metabolite, cefaclor and cephalexin in human plasma, serum and urine.
Kovach PM; Lantz RJ; Brier G
J Chromatogr; 1991 Jun; 567(1):129-39. PubMed ID: 1918240
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
